George de Urioste - 12 Jun 2024 Form 4 Insider Report for HeartBeam, Inc. (BEAT)

Role: Director
Signature: /s/ George de Urioste
Issuer symbol: BEAT
Transactions as of: 12 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Jun 2024, 15:27:41 UTC
Previous filing: 03 Oct 2023
Next filing: 27 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAT	Common Stock	Award	$0	+33,185	+92%	$0.000000	69,314	12 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BEAT	Common Stock (right to buy)						44,000	12 Jun 2024	Common Stock	44,000	$4.25	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.
F2	The option was granted on November 12, 2021 and will vest one forty-eighth of the shares on each one-month anniversary of the vesting commencement date of September 27, 2021, such that 100% of the shares subject to the option will be fully vested and exercisable.

Content

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

The option was granted on November 12, 2021 and will vest one forty-eighth of the shares on each one-month anniversary of the vesting commencement date of September 27, 2021, such that 100% of the shares subject to the option will be fully vested and exercisable.